Rate My Professor Gergely Toldi

Toldi's research focuses on immunology and neonatology, employing flow cytometry to study immune cell characteristics in newborns, preterm infants, pregnant women, and autoimmune disease patients. His investigations address preterm complications like inflammation-driven lung, heart, bowel, and brain injuries, leading projects such as the anakinra pilot trial for very preterm babies in collaboration with Australian institutions. He has authored numerous publications, including the highly influential "Guidelines for the use of flow cytometry and cell sorting in immunological studies" (2019), "Recommendations for diagnosis and treatment of methemoglobinemia" (2021), "Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia" (2011), and "Decreased number of FoxP3+ regulatory T cells in preeclampsia" (2008). Toldi has been honored with the Junior Prima Award (2015, Hungary), Medis Award for scientific work (2016), and the André Mischke Young Academy of Europe Prize for Science and Policy (2022). He supervises PhD and undergraduate students, trains medical students in neonatal examination and resuscitation, delivers public lectures on breastfeeding's role in immune development, and serves on committees such as the Medical Research Foundation of New Zealand. Through international collaborations with researchers in Hungary, Australia, Germany, Finland, Japan, and Ireland, Toldi advances neonatal immunology, enhancing diagnostic and therapeutic options for vulnerable infants.